Exagen Inc. Elects Tina S. Nova, Ph.D. As Executive Chair Of The Board Of Directors
Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive Chair of the Exagen Board of Directors, effective January 19,